HYPER-IGM

Clinical trials for HYPER-IGM explained in plain language.

Never miss a new study

Get alerted when new HYPER-IGM trials appear

Sign up with your email to follow new studies for HYPER-IGM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Milder stem cell transplant offers hope for kids with rare immune diseases

Disease control Ongoing

This study tests a stem cell transplant for children and young adults up to age 28 with serious immune system disorders. The goal is to replace their faulty immune cells with healthy donor cells using a milder chemotherapy-like preparation to reduce side effects. The study tracks…

Matched conditions: HYPER-IGM

Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated May 14, 2026 12:02 UTC

HYPER-IGM

Get alerted when new HYPER-IGM trials appear

Milder stem cell transplant offers hope for kids with rare immune diseases